RecruitingPhase 2NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Sponsor: Artiva Biotherapeutics, Inc.
Hixson, TN · Jackson, TN · +29 more sites